NON-CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for NON-CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare kidney cancer: combo therapy aims to stop return after surgery
Disease control OngoingThis study tests whether two drugs—serplulimab and fruquintinib—can keep a rare kidney cancer from coming back after surgery. About 40 adults with high-risk non-clear cell renal cell carcinoma will receive both drugs for up to a year. The goal is to see how long they stay cancer-…
Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New hope for rare kidney cancers? drug combo trial shows promise
Disease control OngoingThis study tests a new two-drug combination (cadonilimab plus axitinib) as a first treatment for people with advanced or spread kidney cancer of rare types. About 37 adults will take the drugs until their disease gets worse or side effects become too severe. The goal is to see if…
Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Hao Zeng • Aim: Disease control
Last updated May 12, 2026 13:39 UTC